Trial Details
TERMINATEDBasic Information
| Clinical ID | c1005 |
|---|---|
| Identifier | NCT04985968 |
| Trial Title | The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Cobitolimod 250 mg|DRUG: Cobitolimod 500 mg|DRUG: Placebo |
Participant Information
| Sponsor | InDex Pharmaceuticals |
|---|---|
| City | Granada Hills |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2021-11-24 |
|---|---|
| Primary Completion Date | 2023-12-20 |
| Completion Date | 2023-12-20 |